We are live on ! Find out more
BCM

Brookmont Capital Management Portfolio holdings

AUM $186M
1-Year Est. Return 10.11%
This Fund
S&P 500
This Quarter Est. Return
-0.9%
1 Year Est. Return
+10.11%
3 Year Est. Return
+36.63%
5 Year Est. Return
+48.26%
10 Year Est. Return
+211.29%
AUM
$177M
AUM Growth
-$9.86M
Cap. Flow
-$6.71M
Cap. Flow %
-3.78%
Top 10 Hldgs %
57.92%
Holding
54
New
Increased
6
Reduced
46
Closed
1

Top Buys

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$1.1M
2
NVDA icon
NVIDIA
NVDA
+$15.2K
3
BWXT icon
BWX Technologies
BWXT
+$3.36K
4
DIS icon
Walt Disney
DIS
+$3.22K
5
AVGO icon
Broadcom
AVGO
+$212

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$1.3M
2
WFC icon
Wells Fargo
WFC
+$635K
3
JPM icon
JPMorgan Chase
JPM
+$513K
4
AJG icon
Arthur J. Gallagher & Co
AJG
+$395K
5
ABT icon
Abbott
ABT
+$354K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 36.37%
2 Financials 13.55%
3 Healthcare 12.1%
4 Technology 7.72%
5 Industrials 7.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HD icon
1
Home Depot
HD
$332B
$59.7M 33.68%
162,898
-515
-0.3% -$201K
AJG icon
2
Arthur J. Gallagher & Co
AJG
$65.9B
$5.86M 3.31%
16,981
-1,251
-7% -$395K
ABT icon
3
Abbott
ABT
$183B
$5.21M 2.94%
39,303
-2,778
-7% -$354K
JPM icon
4
JPMorgan Chase
JPM
$933B
$5.13M 2.89%
20,897
-2,013
-9% -$513K
WFC icon
5
Wells Fargo
WFC
$258B
$4.97M 2.81%
69,268
-8,462
-11% -$635K
MCD icon
6
McDonald's
MCD
$191B
$4.55M 2.57%
14,556
-692
-5% -$207K
SHEL icon
7
Shell
SHEL
$250B
$4.48M 2.53%
61,155
-2,760
-4% -$186K
GILD icon
8
Gilead Sciences
GILD
$163B
$4.31M 2.43%
38,491
-12,592
-25% -$1.3M
HON icon
9
Honeywell
HON
$76.7B
$4.24M 2.39%
21,267
-969
-4% -$196K
PG icon
10
Procter & Gamble
PG
$335B
$4.2M 2.37%
24,645
-1,176
-5% -$197K
MSFT icon
11
Microsoft
MSFT
$3.35T
$4.1M 2.31%
10,919
-497
-4% -$203K
NVO
12
Novo Nordisk
NVO
$228B
$4M 2.26%
57,632
+13,323
+30% +$1.1M
AZN icon
13
AstraZeneca
AZN
$266B
$3.96M 2.24%
26,956
-1,037
-4% -$150K
LHX icon
14
L3Harris
LHX
$50.7B
$3.89M 2.19%
18,566
-781
-4% -$164K
ACN icon
15
Accenture
ACN
$99.9B
$3.57M 2.01%
11,430
-540
-5% -$191K
DD icon
16
DuPont de Nemours
DD
$18.7B
$3.5M 1.97%
37,309
-1,830
-5% -$179K
CVX icon
17
Chevron
CVX
$383B
$3.49M 1.97%
20,867
-939
-4% -$147K
CMCSA icon
18
Comcast
CMCSA
$84B
$3.47M 1.96%
94,148
-3,681
-4% -$133K
COP icon
19
ConocoPhillips
COP
$145B
$2.95M 1.66%
28,064
-1,261
-4% -$126K
USB icon
20
US Bancorp
USB
$98B
$2.92M 1.65%
69,235
-4,462
-6% -$206K
UPS icon
21
United Parcel Service
UPS
$89.5B
$2.89M 1.63%
26,258
-909
-3% -$109K
BAC icon
22
Bank of America
BAC
$433B
$2.84M 1.6%
67,967
-4,564
-6% -$203K
ADI icon
23
Analog Devices
ADI
$179B
$2.81M 1.59%
13,936
-799
-5% -$173K
EQIX icon
24
Equinix
EQIX
$103B
$2.59M 1.46%
3,182
-127
-4% -$114K
PNC icon
25
PNC Financial Services
PNC
$99.2B
$2.3M 1.3%
13,084
-752
-5% -$142K

Similar funds

Brookmont Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Brookmont Capital Management held 54 positions worth $177M, down 5.3% from $187M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Brookmont Capital Management withdrew a net $6.71M in Q1 2025, closing 1 position and reducing 46 holdings. Its most notable exit was Lowe's Companies, an estimated $218K position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 36% of assets, down from 37% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Brookmont Capital Management added an estimated $1.1M to Novo Nordisk.

  • Brookmont Capital Management added most to Novo Nordisk in Q1 2025, an estimated $1.1M increase.
  • Brookmont Capital Management's biggest Q1 2025 reduction was Gilead Sciences, cutting an estimated $1.3M.
  • Brookmont Capital Management fully exited Lowe's Companies in Q1 2025, selling an estimated $218K.
  • Brookmont Capital Management's ten largest holdings make up 58% of its $177M portfolio in Q1 2025.
  • Brookmont Capital Management opened 0 new positions and closed 1 in Q1 2025.
  • Brookmont Capital Management's portfolio value fell 5.3% quarter-over-quarter to $177M.

Based on Brookmont Capital Management's 13F filing for Q1 2025, filed 12 May 2025.